Literature DB >> 9361003

Dentatorubral pallidoluysian atrophy (DRPLA) protein is cleaved by caspase-3 during apoptosis.

T Miyashita1, Y Okamura-Oho, Y Mito, S Nagafuchi, M Yamada.   

Abstract

Dentatorubral pallidoluysian atrophy (DRPLA) is an autosomal dominant neurodegenerative disorder. It is associated with an abnormal CAG repeat expansion resulting in formation of a protein with an elongated polyglutamine stretch. However, neither the physiological roles of the DRPLA gene product nor molecular mechanisms of its pathogenesis have yet been elucidated. Here we report that the DRPLA protein is cleaved at a site near the N terminus during apoptosis induced by VP-16, staurosporine, or glucocorticoid. Moreover, the in vitro translated DRPLA protein is cleaved by recombinant caspase-3, a member of the cysteine protease family, which is thought to be a main executioner of apoptosis. Using mutant DRPLA proteins, the cleavage site was identified as 106DSLDG110. The cleavage, however, was not modulated by the length of the polyglutamine stretch. These findings suggest that the DRPLA protein is one of the physiological substrates of caspase-3, and its cleavage may result in structural and biochemical alterations associated with apoptosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361003     DOI: 10.1074/jbc.272.46.29238

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.

Authors:  Dagmar E Ehrnhoefer; Liza Sutton; Michael R Hayden
Journal:  Neuroscientist       Date:  2011-02-10       Impact factor: 7.519

Review 2.  Pathological accumulation of atrophin-1 in dentatorubralpallidoluysian atrophy.

Authors:  Yasuyo Suzuki; Ikuru Yazawa
Journal:  Int J Clin Exp Pathol       Date:  2011-04-25

3.  Frequent occurrence of protein isoforms with or without a single amino acid residue by subtle alternative splicing: the case of Gln in DRPLA affects subcellular localization of the products.

Authors:  Keiko Tadokoro; Mayu Yamazaki-Inoue; Maki Tachibana; Mina Fujishiro; Kazuaki Nagao; Masashi Toyoda; Miwako Ozaki; Masami Ono; Nobuhiro Miki; Toshiyuki Miyashita; Masao Yamada
Journal:  J Hum Genet       Date:  2005-08-10       Impact factor: 3.172

Review 4.  The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review.

Authors:  R Walsh; E Storey; D Stefani; L Kelly; V Turnbull
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

5.  Characterization of intracellular aggregates using fluorescently-tagged polyglutamine-expanded androgen receptor.

Authors:  V Panet-Raymond; B Gottlieb; L K Beitel; H Schipper; M Timiansky; L Pinsky; M A Trifiro
Journal:  Neurotox Res       Date:  2001-07       Impact factor: 3.911

6.  Polyglutamine-expanded androgen receptor truncation fragments activate a Bax-dependent apoptotic cascade mediated by DP5/Hrk.

Authors:  Jessica E Young; Gwenn A Garden; Refugio A Martinez; Fumiaki Tanaka; C Miguel Sandoval; Annette C Smith; Bryce L Sopher; Amy Lin; Kenneth H Fischbeck; Lisa M Ellerby; Richard S Morrison; J Paul Taylor; Albert R La Spada
Journal:  J Neurosci       Date:  2009-02-18       Impact factor: 6.167

7.  A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living mice.

Authors:  Aurélien Godinat; Hyo Min Park; Stephen C Miller; Ke Cheng; Douglas Hanahan; Laura E Sanman; Matthew Bogyo; Allen Yu; Gennady F Nikitin; Andreas Stahl; Elena A Dubikovskaya
Journal:  ACS Chem Biol       Date:  2013-03-29       Impact factor: 5.100

8.  Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.

Authors:  M K Perez; H L Paulson; S J Pendse; S J Saionz; N M Bonini; R N Pittman
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

Review 9.  Post-translational Modifications and Protein Quality Control in Motor Neuron and Polyglutamine Diseases.

Authors:  Fabio Sambataro; Maria Pennuto
Journal:  Front Mol Neurosci       Date:  2017-03-31       Impact factor: 5.639

10.  Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion.

Authors:  Weiyi Li; Jing Cao; Jian Liu; Wenli Chu; Congqing Zhang; Shuiling Chen; Zefeng Kang
Journal:  Cell Mol Biol Lett       Date:  2019-03-07       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.